Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | JNJ-69086420 |
Synonyms | |
Therapy Description |
JNJ-69086420 is a radiotherapy comprising an antibody targeting KLK2 (hK2) linked to actinium-225, which potentially decreases tumor growth (J Clin Oncol 42, 2024 (suppl 16; abstr 5010). |